# Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

> **NCT00000940** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 121 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Abacavir sulfate
- **DRUG:** Amprenavir
- **DRUG:** Lamivudine
- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00000940
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000940, "Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*